Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes

FASEB Journal

Volumn 14, Issue 3, 2000, Pages 439-447

  Koya, Daisuke ^a   Haneda, Masakazu ^a   Nakagawa, Hiroko ^a   Isshiki, Keiji ^a   Sato, Haruhisa ^b   Maeda, Shiro ^a   Sugimoto, Toshiro ^a   Yasuda, Hitoshi ^a   Kashiwagi, Atsunori ^a   Ways, D Kirk ^c   King, George L ^d   Kikkawa, Ryuichi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b Otowa Hospital   (Japan)

^c ELI LILLY AND COMPANY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Diabetic nephropathy; Fibronectin; Transforming growth factor (TGF ); Type IV collagen

Indexed keywords

COLLAGEN TYPE 4; PROTEIN KINASE C INHIBITOR; RUBOXISTAURIN; SCLEROPROTEIN; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DIABETIC NEPHROPATHY; ENZYME ACTIVATION; ENZYME INHIBITOR INTERACTION; GENE OVEREXPRESSION; MALE; MESANGIUM CELL; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; STREPTOZOCIN DIABETES;

ANIMALIA; RODENTIA;

EID: 0034053336     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.14.3.439     Document Type: Article

References (60)

1. Renal Data System. (April 1998) USRDS 1998 Annual Data Report, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Md. (NIH publication no. 98-3176)
2. The Diabetes Control and Complications Trial Research Group. (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N. Engl. J. Med. 329, 977-986
3. UK Prospective Diabetes Study (UKPDS) Group. (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352, 837-53
4. Fioretto, P., Steffes, M. W., Sutherland, D. E., Goetz, F. C., and Mauer, M. (1998) Reversal of lesions of diabetic nephropathy after pancreas transplantation. N. Engl. J. Med. 339, 69-75
5. Derubertis, F. R., and Craven, P. A. ( 1994) Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes 43, 1-8
6. Koya, D., and King, G. L. (1998) Protein kinase C activation and the development of diabetic complications. Diabetes 47, 859-66
7. Haneda, M., Araki, S., Togawa, M., Sugimoto, T., Isono, M., and Kikkawa, R. (1997) Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 46, 847-853
8. Murphy, M., McGinty, A., and Godson, C. (1998) Protein kinases C: potential targets for intervention in diabetic nephropathy. Curr. Opin. Nephrol. Hypertens. 7, 563-570
9. Kikkawa, R., Umemura, K., Haneda, M., Arimura, T., Ebata, K., and Shigeta, Y. (1987) Evidence for existence of polyol pathway in cultured rat mesangial cells. Diabetes 36, 240-243
10. Greene, D. A., Lattimer, S. A., and Sima, A. A. (1987) Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N. Engl. J. Med. 316, 599-606
11. Haneda, M., Kikkawa, R., Arimura, T., Ebata, K., Togawa, M., Maeda, S., Sawada, T., Horide, N., and Shigeta, Y. (1990) Glucose inhibits myo-inositol uptake and reduces myo-inositol content in cultured rat glomerular mesangial cells. Metabolism 39, 40-45
12. Williamson, J. R., Chang, K., Frangos, M., Hasan, K. S., Ido, Y., Kawamura, T., Nyengaard, J. R., van, den, Enden, M., Kilo, C., and Tilton, R. G. (1993) Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42, 801-813
13. Suzuki, D., Miyata, T., Saotome, N., Horie, K., Inagi, R., Yasuda, Y., Uchida, K., Izuhara, Y., Yagame, M., Sakai, H., and Kurokawa, K. (1999) Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions. J. Am. Soc. Nephrol. 10, 822-832
14. Brownlee, M., Cerami, A., and Vlassara, H. (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318, 1315-1321
15. Sharma, K., and Ziyadeh, F. N. (1995) Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-β as a key mediator. Diabetes 44, 1139-1146
16. Craven, P. A., Davidson, C. M., and DeRubertis, F. R. (1990) Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes 39, 667-674
17. Craven, P. A., and DeRubertis, F. R. (1989) Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose. J. Clin. Invest. 83, 1667-1675
18. Koya, D., Jirousek, M. R., Lin, Y. W., Ishii, H., Kuboki, K., and King, G. L. (1997) Characterization of protein kinase C β isoform activation on the gene expression of transforming growth factor-β, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J. Clin. Invest. 100, 115-126
19. Ishii, H., Jirousek, M. R., Koya, D., Takagi, C., Xia, P., Clermont, A., Bursell, S. E., Kern, T. S., Ballas, L. M., Heath, W. F., Stramm, L. E., Feener, E. P., and King, G. L. (1996) Amelioration of vascular dysfunctions in diabetic rats by an oral PKC β inhibitor. Science 272, 728-731
20. Babazono, T., Kapor, D. J., Dlugosz, J. A., and Whiteside, C. (1998) Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells. Diabetes 47, 668-676
21. Ayo, S. H., Radnik, R., Garoni, J. A., Troyer, D. A., and Kreisberg, J. I. (1991) High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am. J. Physiol. 261, F57-F577
22. Kikkawa, R., Haneda, M., Uzu, T., Koya, D., Sugimoto, T., and Shigeta, Y. (1994) Translocation of protein kinase C α and ζ in rat glomerular mesangial cells cultured under high glucose conditions. Diabetologia 37, 838-841
23. Xia, P., Aiello, L. P., Ishii, H., Jiang, Z. Y., Park, D. J., Robinson, G. S., Takagi, H., Newsome, W. P., Jirousek, M. R., and King, G. L. (1996) Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J. Clin. Invest. 98, 2018-2026
24. Sharma, K., Danoff, T. M., DePiero, A., and Ziyadeh, F. N. (1995) Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels: possible mediation via protein kinase C. Biochem. Biophys. Res. Commun. 207, 80-88
25. Ellis, E. N., Steffes, M. W., Goetz, F. C., Sutherland, D. E., and Mauer, S. M. (1986) Glomerular filtration surface in type I diabetes mellitus. Kidney Int. 29, 889-894
26. Fioretto, P., Steffes, M. W., and Mauer, M. (1994) Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria. Diabetes 43, 1358-1364
27. Steffes, M. W., Osterby, R., Chavers, B., and Mauer, S. M. (1989) Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38, 1077-1081
28. Nakao, N., Hiraiwa, N., Yoshiki, A., Ike, F., and Kusakabe, M. (1998) Tenascin-C promotes healing of Habu-snake venom-induced glomerulonephritis: studies in knockout congenic mice and in culture. Am. J. Pathol. 152, 1237-1245
29. Koya, D., Lee, I. K., Ishii, H., Kanoh, H., and King, G. L. (1997) Prevention of glomerular dysfunction in diabetic rats by treatment with d-α-tocopherol. J. Am. Soc. Nephrol. 8, 426-435
30. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254
31. Hugo, C., Hugo, C., Pichler, R., Gordon, K., Schmidt, R., Amieva, M., Couser, W. G., Furthmayr, H., and Johnson, R. J. (1996) The cytoskeletal linking proteins, moesin and radixin, are upregulated by platelet-derived growth factor, but not basic fibroblast growth factor in experimental mesangial proliferative glomerulonephritis. J. Clin. Invest. 97, 2499-2508
32. Yoshimura, A., Gordon, K., Alpers, C. E., Floege, J., Pritzl, P., Ross, R., Couser, W. G., Bowen, P. D., and Johnson, R. J. (1991) Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization. Kidney Int. 40, 470-476
33. Falk, R. J., Scheinman, J. I., Mauer, S. M., and Michael, A. F. (1983) Polyantigenic expansion of basement membrane constituents in diabetic nephropathy. Diabetes 2, 34-39
34. Zhu, D., Kim, Y., Steffes, M. W., Groppoli, T. J., Butkowski, R. J., and Mauer, S. M. (1994) Glomerular distribution of type IV collagen in diabetes by high resolution quantitative immunochemistry. Kidney Int. 45, 425-433
35. Adler, S. ( 1994) Structure-function relationships associated with extracellular matrix alterations in diabetic glomerulopathy [editorial]. J. Am. Soc. Nephrol. 5, 1165-1172
36. Border, W. A., and Noble, N. A. (1994) Transforming growth factor beta in tissue fibrosis. N. Engl. J. Med. 331, 1286-1292
37. Mauer, S. M., Steffes, M. W., Ellis, E. N., Sutherland, D. E., Brown, D. M., and Goetz, F. C. (1984) Structural-functional relationships in diabetic nephropathy. J. Clin. Invest. 74, 1143-1155
38. Lee, S. M., and Graham, A. (1980) Early immunopathologic events in experimental diabetic nephropathy: a study in db/db mice. Exp. Mol. Pathol. 33, 323-332
39. Cohen, M. P., Sharma, K., Jin, Y., Hud, E., Wu, V. Y., Tomaszewski, J., and Ziyadeh, F. N. (1995) Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy. J. Clin. Invest. 95, 2338-2345
40. Fukui, M., Nakamura, T., Ebihara, I., Shirato, I., Tomino, Y., and Koide, H. (1992) ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 41, 1520-1527
41. Peten, E. P., Striker, L. J., Carome, M. A., Elliott, S. J., Yang, C. W., and Striker, G. E. (1992) The contribution of increased collagen synthesis to human glomerulosclerosis: a quantitative analysis of alpha 2IV collagen mRNA expression by competitive polymerase chain reaction. J. Exp. Med. 176, 1571-1576
42. Ledbetter, S., Copeland, E. J., Noonan, D., Vogeli, G., and Hassell, J. R. (1990) Altered steady-state mRNA levels of basement membrane proteins in diabetic mouse kidneys and thromboxane synthase inhibition. Diabetes 39, 196-203
43. Ihm, C. G., Lee, G. S., Nast, C. C., Artishevsky, A., Guillermo, R., Levin, P. S., Glassock, R. J., and Adler, S. G. (1992) Early increased renal procollagen alpha 1(IV) mRNA levels in streptozotocin induced diabetes. Kidney Int. 41, 768-777
44. Young, B. A., Johnson, R. J., Alpers, C. E., Eng, E., Gordon, K., Floege, J., Couser, W. G., and Seidel, K. (1995) Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int. 47, 935-944
45. Ziyadeh, F. N., Sharma, K., Ericksen, M., and Wolf, G. (1994) Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J. Clin. Invest. 93, 536-542
46. Sharma, K., and Ziyadeh, F. N. (1994) Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse. Am. J. Physiol. 267, F1094-F1101
47. Sharma, K., Jin, Y., Guo, J., and Ziyadeh, F. N. (1996) Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45, 522-530
48. Yamamoto, T., Nakamura, T., Noble, N. A., Ruoslahti, E., and Border, W. A. (1993) Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc. Natl. Acad. Sci. USA 90, 1814-1818
49. Cohen, M. P., Sharma, K., Guo, J., Eltayeb, B. O., and Ziyadeh, F. N. (1998) The renal TGF-beta system in the db/db mouse model of diabetic nephropathy. Exp. Nephrol. 6, 226-233
50. Kim, S. J., Denhez, F., Kim, K. Y., Holt, J. T., Sporn, M. B., and Roberts, A. B. (1989) Activation of the second promoter of the transforming growth factor-β1 gene by transforming growth factor-β1 and phorbol ester occurs through the same target sequences. J. Biol. Chem. 264, 19373-19378
51. Geiser, A. G., Kim, S. J., Roberts, A. B., and Sporn, M. B. (1991) Characterization of the mouse transforming growth factor-beta 1 promoter and activation by the Ha-ras oncogene. Mol. Cell. Biol. 11, 84-92
52. Kreisberg, J. I., Radnik, R. A., Ayo, S. H., Garoni, J., and Saikumar, P. (1994) High glucose elevates c-fos and c-jun transcripts and proteins in mesangial cell cultures. Kidney Int. 46, 105-112
53. Muro, A. F., Bernath, V. A., and Kornblihtt, A. R. (1992) Interaction of the -170 cyclic AMP response element with the adjacent CCAAT box in the human fibronectin gene promoter. J. Biol. Chem. 267, 12767-12774
54. Dean, D. C., McQuillan, J. J., and Weintraub, S. (1990) Serum stimulation of fibronectin gene expression appears to result from rapid serum-induced binding of nuclear proteins to a cAMP response element. J. Biol. Chem. 265, 3522-3527
55. Sassone, C. P., Ransone, L. J., and Verma, I. M. (1990) Cross-talk in signal transduction: TPA-inducible factor jun/AP-1 activates cAMP-responsive enhancer elements. Oncogene 5, 427-431
56. Andersen, A. R., Christiansen, J. S., Andersen, J. K., Kreiner, S., and Deckert, T. (1983) Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25, 496-501
57. Krolewski, A. S., Warram, J. H., Christlieb, A. R., Busick, E. J., and Kahn, C. R. (1985) The changing natural history of nephropathy in type I diabetes. Am. J. Med. 78, 785-794
58. Rossing, P., Rossing, K., Jacobsen, P., and Parving, H. H. (1995) Unchanged incidence of diabetic nephropathy in IDDM patients. Diabetes 44, 739-743
59. Ballard, D. J., Humphrey, L. L., Melton, L. 3., Frohnert, P. P., Chu, P. C., O'Fallon, W. M., and Palumbo, P. J. (1988) Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota. Diabetes 37, 405-412
60. Kunzelman, C. L., Knowler, W. C., Pettitt, D. J., and Bennett, P. H. (1989) Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians. Kidney Int. 35, 681-687